ATLANTA, GA--(Marketwire - August 2, 2010) - ALR Technologies Inc. (
The article is titled "Effect of Internet Therapeutic Intervention on A1C Levels in Patients With Type 2 Diabetes Treated With Insulin" and showed A1C dropping from 8.8% to 7.6% for the Intervention Group using ALRT's HeC System. The A1C test is important in diabetes treatment management as a long-term measure of control over blood glucose for diabetes patients. According to Centers for Disease Control and Prevention, "In general, every percentage drop in A1C blood test results (e.g. from 8% to 7%), can reduce the risk of microvascular complications (eye, kidney and nerve diseases) by 40%."
Dr. Tildesley commented, "The effectiveness of using ALRT HeC System compares favorably to the recently introduced diabetes medications but at a lower cost with no side effects."
Without using the ALRT HeC System to monitor the patients in the post study period, the A1C values for the Intervention Group returned to base levels. These data are expected to be published in a separate article.
The Company recently announced the July 23, 2010 filing of a 510(k) with the FDA for the ALRT HeC System. The System will be available for sale in the U.S. pending 510(k) clearance expected before the end of 2010.
About ALR Technologies Inc.
ALRT Health-e-Connect (HeC) System is the principal product of the Company. HeC is a web based application for medical professionals to improve compliance and adherence of care plans of patients in their homes. HeC is programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at http://www.alrt.com.
This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.
Contact Information:
Public Relations:
678-881-0002 Ext. 704
e-mail: